e-learning
resources
ERJ
2004
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Unlicensed and off-label prescription of respiratory drugs to children
't Jong G.W., Eland I.A., Sturkenboom M.C.J.M., van den Anker J.N., Stricker B.H.C.
Source:
Eur Respir J 2004; 23: 310-313
Journal Issue:
February
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
't Jong G.W., Eland I.A., Sturkenboom M.C.J.M., van den Anker J.N., Stricker B.H.C.. Unlicensed and off-label prescription of respiratory drugs to children. Eur Respir J 2004; 23: 310-313
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: respiratory care for newborns in resource-limited settings
Respiratory sequelae of preterm birth across the life span
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
Respiratory medicines for children: current evidence, unlicensed use and research priorities
Source: Eur Respir J 2010; 35: 247-265
Year: 2010
Prescribing patterns of antiasthma medication in children and adolescents in primary care in France.
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020
The drug costs associated with COPD prescription medicine in Denmark
Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Year: 2012
Changes in the use of anti-asthmatic medication in an international cohort
Source: Eur Respir J 2005; 26: 1047-1055
Year: 2005
Antibiotic use and misuse in the community: how to manage the problem
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006
New and repurposed TB drugs use in children and adolescents with M/XDR-TB
Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now?
Year: 2017
Data-driven prescription patterns in patients under maintenance treatment for respiratory diseases from the Portuguese prescription database
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
Rescue/acute and allergy medication use among children on asthma controller therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 378s
Year: 2004
The use of electronic alerts in primary care to identify the over-prescription of short-acting beta2-agonists in people with asthma: a systematic review
Source: International Congress 2017 – Primary care management of asthma and COPD
Year: 2017
Are smokers with acute cough in primary care prescribed antibiotics more often, and to what benefit? An observational study in 13 European countries
Source: Eur Respir J 2010; 35: 761-767
Year: 2010
Do general practitioners use effective communication for discussing patients‘ adherence with asthma medications?
Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Year: 2012
Inappropriate overuse of inhaled corticosteroids in patients with moderate COPD in UK primary care
Source: Annual Congress 2011 - Disease management in specific primary care populations
Year: 2011
Managing pediatric pneumonia by following guidelines to decrease the use of concurrent asthma medication.
Source: International Congress 2019 – Paediatric respiratory infections around the world: Tuberculosis, pneumonia and others
Year: 2019
How often do asthma patients claim prescribed therapy?
Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS
Year: 2017
Trends in antibiotic use in children with asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 133s
Year: 2003
Biologic therapies in paediatric severe asthma
Source: ERS webinar 2020: Biologic therapies in paediatric severe asthma
Year: 2020
De-implementing inappropriate inhaled steroids use in Dutch COPD patients in primary care
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
In a rural part of Canada, a study of the treatment of asthma attacks shows an over utilisation of salbutamol nebulization and of antibiotics, a less frequent use of steroid inhalation treatments, a lower incidence of environmental modification teaching a
Source: Eur Respir J 2003; 22: Suppl. 45, 409s
Year: 2003
The prevalence of symptoms suggestive of COPD amongst patients attending an illicit drug misuse clinic
Source: Annual Congress 2013 –COPD and tobacco management
Year: 2013
Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance
Source: Eur Respir J 2012; 39: 802-804
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept